Bristol Myers Squibb (BMY) Intangibles (2009 - 2026)
Bristol Myers Squibb (BMY) reported Intangibles of $17.39 billion for Q2 2026, down 18.7% from $21.38 billion a year earlier and down 4.7% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Intangibles of $19.1 billion, down 18.0% from FY2024.
- Intangibles has declined for six consecutive years, with a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
- By year, Intangibles came in at $23.31 billion in FY2024 (-13.9%), $27.07 billion in FY2023 (-24.5%), $35.86 billion in FY2022 (-15.7%) and $42.53 billion in FY2021 (-20.1%).
- The Q2 2026 figure ranks as the lowest quarterly Intangibles since Q3 2019.
- Year over year, Intangibles has now declined in each of the last 23 quarters, with an average decline of 19.9% over the last eight quarters.
- Across the past five years, year-over-year decline in Intangibles ran from 2.4% in Q1 2024 to 31.4% in Q1 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $18.24 billion (Q1 2026), $19.1 billion (Q4 2025) and $20.47 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,153.61 Bn | 1,122.20 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 624.26 Bn | 542.79 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 512.23 Bn | 485.34 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 365.41 Bn | 319.79 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 297.24 Bn | 261.23 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 234.57 Bn | 189.97 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 192.81 Bn | 167.01 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Bristol Myers Squibb | 125.59 Bn | 76.87 Bn | 9.25 Bn | 17.39 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.39 Bn |
| Mar 31, 2026 | 18.24 Bn |
| Dec 31, 2025 | 19.10 Bn |
| Sep 30, 2025 | 20.47 Bn |
| Jun 30, 2025 | 21.38 Bn |
| Mar 31, 2025 | 22.49 Bn |
| Dec 31, 2024 | 23.31 Bn |
| Sep 30, 2024 | 26.96 Bn |
| Jun 30, 2024 | 29.43 Bn |
| Mar 31, 2024 | 32.76 Bn |
| Dec 31, 2023 | 27.07 Bn |
| Sep 30, 2023 | 28.95 Bn |
| Jun 30, 2023 | 31.30 Bn |
| Mar 31, 2023 | 33.57 Bn |
| Dec 31, 2022 | 35.86 Bn |
| Sep 30, 2022 | 38.18 Bn |
| Jun 30, 2022 | 37.69 Bn |
| Mar 31, 2022 | 40.10 Bn |
| Dec 31, 2021 | 42.53 Bn |
| Sep 30, 2021 | 44.93 Bn |
API Access
Bristol Myers Squibb Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();